NASDAQ:RPID - Nasdaq - US75340L1044 - Common Stock - Currency: USD
Taking everything into account, RPID scores 2 out of 10 in our fundamental rating. RPID was compared to 54 industry peers in the Life Sciences Tools & Services industry. The financial health of RPID is average, but there are quite some concerns on its profitability. RPID is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -52.47% | ||
ROE | -68.45% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 6.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -2.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.61 | ||
Quick Ratio | 3.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:RPID (7/25/2025, 8:23:13 PM)
4.08
-0.26 (-5.99%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 6.03 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.73 | ||
P/tB | 2.73 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -52.47% | ||
ROE | -68.45% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 6.13% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 32.3% | ||
Cap/Sales | 3.71% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.61 | ||
Quick Ratio | 3.23 | ||
Altman-Z | -2.97 |